Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

AI used to forecast cancer progression

September 3, 2018 Sales and Marketing AI, Cancer, ICR, London, ai drug research and development, university of edinburgh

A team of scientists at the Institute of Cancer Research (ICR) in London and the University of Edinburgh have developed …
News
28246711066_52e38bc591_z

MHRA loses EMA contracts in wake of Brexit

September 3, 2018 Sales and Marketing EMA, MHRA, UK, brexit, contracts, politics, regulation

The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten

Eight months of 2018 down – where has the year gone? As we move from August into September, and a …
News

DIA’s Global Clinical Trials Transparency Conference & Clinical Trials Regulations Conference

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Disclosure and transparency of clinical trial information is taking on new dimensions in the EU and US. Moreover, while the …
News
Press release
shire_image

Shire hands over its oncology franchise to Servier for $2.4bn

August 31, 2018 Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale

Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …
News

Bristol-Myers Squibb appoints Christopher Boerner as new Executive Vice President and Chief Commercial Officer

August 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon

Bristol Myers Squibb has announced that Dr Christopher Boerner will take over from Murdo Gordon as executive Vice President and …
Appointment
credit_natural_cycles

Contraceptive app Natural Cycles investigated over “misleading” efficacy claims

August 30, 2018 Medical Communications, Sales and Marketing APP Pharma, Natural Cycles, UK, app. pharma

The company behind Natural Cycles, the first-ever approved smartphone app promising a natural alternative to contraception, has seen a Facebook …
News
astrazeneca_building_white

AstraZeneca’s once-weekly auto-injector Bydureon BCise wins EU approval in type 2 diabetes

August 30, 2018 Research and Development, Sales and Marketing AstraZeneca, Bydureon, EU, Europe, diabetes, pharma, type 2 diabetes

AstraZeneca has announced that its auto-injector Bydureon BCise (exenatide 2mg prolonged-release suspension) has been approved by the European Commission for …
News
jazz_pharma

Jazz Pharma’s acute myeloid leukaemia drug scores EU approval

August 29, 2018 Research and Development, Sales and Marketing Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, leukaemia, pharma

Jazz Pharmaceuticals has revealed that its advanced liposomal formulation Vyxeos has received approval from the European Commission for the treatment …
News
shutterstock_168864905

Emergent snaps up Adapt and its opioid overdose therapy for $735m

August 29, 2018 Research and Development, Sales and Marketing Emergent, Narcan, naloxone, opioid crisis, opioids, pharma

Emergent BioSolutions has announced it has signed an agreement to acquire Adapt Pharma at a valuation of $735 million, a …
News
eisa0008_web

Eisai’s weight loss drug lorcaserin found safe in major study

August 28, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Eisai, lorcaserin, safety, study, weight loss

Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according to a study of 12,000 …
News

Ionis/Akcea’s ultra-rare disease drug rejected by FDA

August 28, 2018 Manufacturing and Production, Sales and Marketing Akcea, FDA, Ionis, familial chylomicronemia syndrome, pharma, rare disease

The FDA has opted to refuse approval to Akcea and Ionis’ Waylivra (volanesorsen) for the treatment of the ultra-rare hereditary …
News
26022266362_1bf5a2747e_z

Researchers develop anti-nicotine addiction drugs

August 28, 2018 Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university

Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …
News
european_commission_web

Novartis’ Kymriah & Gilead’s Yescarta become first EU-approved CAR T therapies

August 28, 2018 Manufacturing and Production, Sales and Marketing CAR T, CAR-T, Cancer, EU, Gilead, Kymriah, Novartis, UK, Yescarta, blood cancer, pharma

Almost one full year since the treatment was given a “historic” approval in the US, Novartis’ CAR T therapy Kymriah …
News
social_media_phone_iphone_twitter_hand-38920

Russian trolls spread vaccine misinformation on Twitter

August 28, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines

Twitter bots and Russian trolls post content about vaccination at significantly higher rates than normal users, a new study has …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026